QA: Tenax Therapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2019_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 13,320,240
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,525
3 remainder_Assets 8,435
4 LiabilitiesCurrent 1,565,669
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,657,599
9 ResearchAndDevelopmentExpense 1,867,370
10 remainder_Expenses 4,207,082
11 remainder_Revenues 0
12 remainder_NetIncome 125,508
13 remainder_ComprehensiveNetIncome 24,797,394
  yvar yval
0 Assets 13,337,200
1 Liabilities 1,565,669
2 Expenses 11,732,051
3 Revenues 0
4 StockholdersEquity 11,771,531
5 NetIncome -11,606,543
6 ComprehensiveNetIncome 792,154
7 BaseVar 25,778,911
8 EconomicCapitalRatiobeforeLimitedLiability 3.55
9 EconomicCapitalRatio 4.06

Edgar->Model Mapping

Feature Distribution

Change over Time